Bendazac
Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.594 ![]() |
Chemical and physical data | |
Formula | C16H14N2O3 |
Molar mass | 282.299 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Synthesis
Principal action is inhibition of protein denaturation.

Bendazac synthesis: BE 699226; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).
gollark: Entrance polls?
gollark: 3 or so.
gollark: The election period should last a few days.
gollark: Everyone make their own voting system. We can have them all go live on election day then decide which to use with a vote.
gollark: Kepler: we won't.
See also
References
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.